Omnicell (NASDAQ:OMCL) PT Lowered to $26.00

Omnicell (NASDAQ:OMCL – Get Free Report) had its price target dropped by equities research analysts at Wells Fargo & Company from $28.00 to $26.00 in a research note issued on Friday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective suggests a potential downside of […]

Leave a Reply

Your email address will not be published.

Previous post BILL (NYSE:BILL) Price Target Raised to $83.00
Next post Molina Healthcare (NYSE:MOH) Price Target Increased to $406.00 by Analysts at Cantor Fitzgerald